← Back to Search

Web-Based Intervention for Preventing Impaired Driving Among Adolescents (webCHAT Trial)

N/A
Recruiting
Led By Karen Osilla, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through month 6
Awards & highlights

webCHAT Trial Summary

This trialwill test if a web-based intervention can reduce impaired driving among teenage drivers.

Who is the study for?
This trial is for teens aged 15.5 to 17 who are enrolled in driver education programs and will take their driving test within a month. They must have access to a computer or smartphone and speak English. It's not open to those outside the age range, not in participating schools, or non-English speakers.Check my eligibility
What is being tested?
The study is testing webCHAT, an online program designed to prevent impaired driving among adolescents. Participants will either receive this single-session intervention or stick with the usual driver's education curriculum (usual care).See study design
What are the potential side effects?
Since webCHAT is a behavioral intervention involving no medication, there are no direct physical side effects expected from participation in this trial.

webCHAT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol and/or Cannabis use (scale from Monitoring the Future survey)
Secondary outcome measures
Driving under the influence behaviors (scale from Monitoring the Future survey)
Passenger driving behavior behaviors (scale from Monitoring the Future survey)

webCHAT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: webCHATExperimental Treatment1 Intervention
Single session 20-40minute self-guided web program that discusses promotes healthy decision making around driving and discusses the risks of alcohol and cannabis-influenced driving.
Group II: Usual CareActive Control1 Intervention
Existing driving school education

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,388 Previous Clinical Trials
17,334,277 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
800 Previous Clinical Trials
1,362,861 Total Patients Enrolled
Karen Osilla, PhDPrincipal InvestigatorProfessor
1 Previous Clinical Trials
500 Total Patients Enrolled

Media Library

Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT04959461 — N/A
Substance Use Disorders Research Study Groups: webCHAT, Usual Care
Substance Use Disorders Clinical Trial 2023: Usual Care Highlights & Side Effects. Trial Name: NCT04959461 — N/A
Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04959461 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For what age range is enrollment in this clinical trial available?

"This trial mandates that patients must be between the age of 15 and 17 to meet the eligibility requirements."

Answered by AI

What is the scope of this research project in terms of participants?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial, first announced on January 1st 2022, is still looking to recruit patients. The study aims to enrol 150 individuals from two different sites."

Answered by AI

Is there an opportunity to become involved in this clinical research?

"Eligibility for this experiment is contingent on having a history of drug abuse and being between the ages 15 to 17. Consequently, up to 150 adolescents may partake in this trial."

Answered by AI

Is this experiment recruiting participants right now?

"Affirmative, the information found on clinicaltrials.gov reveals that this research venture is currently seeking participants. First posted on January 1st 2022 and subsequently updated November 2nd of the same year, 150 prospective patients are needed for enrollment at two distinct medical centres."

Answered by AI
~5 spots leftby May 2024